Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-12 5:05 pm Unchanged | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | Stonepine Capital Management LLC | 0 0% | 0 (Unchanged) | View |
| 2021-02-11 12:58 pm Sale | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | Samjo Capital LLC | 389,713 8.2% | -2,972,287 (-88.41%) | View |
| 2020-05-26 9:11 pm Unchanged | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | Blue Water Life Science Master Fund Ltd. | 5,790,269 0% | 0 (Unchanged) | View |
| 2020-03-19 6:48 pm Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | LYTTON LAURENCE W | 5,127,000 5.2% | 2,284,104 (+80.34%) | View |
| 2020-02-27 4:07 pm Sale | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | LYTTON LAURENCE W | 2,842,896 4.99% | -3,964,400 (-58.24%) | View |
| 2020-02-14 1:30 pm Sale | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | PRICE T ROWE ASSOCIATES INC | 1,396,946 2.4% | -602,154 (-30.12%) | View |
| 2020-02-14 12:23 pm Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | Nantahala Capital Management LLC | 5,000,000 8.6% | 5,000,000 (New Position) | View |
| 2020-02-13 5:56 pm Sale | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | Serrado Capital LLC | 780,328 1.3% | -2,611,751 (-77.00%) | View |
| 2020-02-13 4:36 pm Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | Stonepine Capital Management LLC | 5,913,812 9.99% | 3,237,923 (+121.00%) | View |
| 2020-02-04 10:35 am Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | Cowen Prime Services LLC | 3,573,000 6.15% | 3,573,000 (New Position) | View |
| 2020-01-31 3:29 pm Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | Samjo Capital LLC | 3,362,000 5.8% | 3,362,000 (New Position) | View |
| 2019-10-10 11:35 am Sale | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | FMR LLC | 2,692,976 4.642% | -914,873 (-25.36%) | View |
| 2019-10-01 11:05 am Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | Serrado Capital LLC | 3,392,079 5.8% | 3,392,079 (New Position) | View |
| 2019-09-30 08:38 am Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | Blue Water Life Science Master Fund Ltd. | 5,790,269 9.9% | 5,790,269 (New Position) | View |
| 2019-09-27 6:19 pm Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | LYTTON LAURENCE W | 6,807,296 11.7% | 5,305,918 (+353.40%) | View |
| 2019-07-01 1:39 pm Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGMQ | LYTTON LAURENCE W | 1,501,378 5.2% | 1,501,378 (New Position) | View |